Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?

Silke Tribius; E Reemts; Christine Prosch; M Raguse; Cordula Petersen; Andreas Krüll; S Singer; Corinna Bergelt

Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?

Standard

Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline? / Tribius, Silke; Reemts, E; Prosch, Christine; Raguse, M; Petersen, Cordula ; Krüll, Andreas; Singer, S; Bergelt, Corinna.

In: ORAL ONCOL, Vol. 48, No. 9, 9, 2012, p. 898-904.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Tribius, S, Reemts, E, Prosch, C, Raguse, M, Petersen, C , Krüll, A, Singer, S & Bergelt, C 2012, 'Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?', ORAL ONCOL, vol. 48, no. 9, 9, pp. 898-904. <http://www.ncbi.nlm.nih.gov/pubmed/22502815?dopt=Citation>

APA

Tribius, S., Reemts, E., Prosch, C., Raguse, M., Petersen, C., Krüll, A., Singer, S., & Bergelt, C. (2012). Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline? ORAL ONCOL, 48(9), 898-904. [9]. http://www.ncbi.nlm.nih.gov/pubmed/22502815?dopt=Citation

Vancouver

Tribius S, Reemts E, Prosch C, Raguse M, Petersen C , Krüll A et al. Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline? ORAL ONCOL. 2012;48(9):898-904. 9.

Bibtex

@article{9ef91a825afb4d6da24263ea5e8b594d,

title = "Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?",

abstract = "Treatment intensification has improved outcomes for patients with head and neck cancer (HNC), but little has been reported on health-related quality of life (QoL) consequences. We investigated changes in QoL after (chemo)radiotherapy to identify patient characteristics that predict those whose QoL deteriorates most profoundly in the acute post-treatment period.",

keywords = "Humans, Male, Aged, Female, Middle Aged, Prospective Studies, Regression Analysis, Combined Modality Therapy, *Quality of Life, Radiotherapy/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Head and Neck Neoplasms/*drug therapy/*radiotherapy, Humans, Male, Aged, Female, Middle Aged, Prospective Studies, Regression Analysis, Combined Modality Therapy, *Quality of Life, Radiotherapy/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Head and Neck Neoplasms/*drug therapy/*radiotherapy",

author = "Silke Tribius and E Reemts and Christine Prosch and M Raguse and Cordula Petersen and Andreas Kr{\"u}ll and S Singer and Corinna Bergelt",

year = "2012",

language = "English",

volume = "48",

pages = "898--904",

journal = "ORAL ONCOL",

issn = "1368-8375",

publisher = "Elsevier Limited",

number = "9",